摘要
目的:探讨shRNA干扰沉默PLCε基因对人膀胱癌T24细胞生长的影响。方法:体外构建PLCε基因的shRNA的重组质粒,Lipofectamine2000介导法转染T24细胞,采用RT-PCR方法检测特异性shRNA的重组质粒对PLCε基因沉默效果,转染后采用MTT法检测shRNA的重组质粒对细胞增殖的作用,免疫细胞化学染色法检测T24细胞PCNA的表达,电镜观察细胞超微结构的改变。结果:shRNA的重组质粒能有效下调PLCε基因的表达,抑制率为78.01%,与对照组比较其差异有统计学意义(P<0.01);细胞增殖活性受到明显抑制,与对照组比较其差异有统计学意义(P<0.01);细胞内PCNA含量明显低于空白对照组和阴性质粒组,其差异有统计学意义(P<0.01);细胞形态改变产生凋亡小体。结论:PLCε基因有望成为应用RNAi技术探索治疗膀胱癌潜在的靶基因。
Objective:To investigate whether PLCε gene down regulation by RNA interference(RNAi) leads to inhibition of proliferation in human bladder carcinoma T24 cell.Methods: The shRNA recombinant plasmids targeting to PLCε gene was constructed and transfected into bladder carcinoma T24 cell with Lipofectamine 2000.RT-PCR was used to monitor the validity of specific s h R N A in down regulation of PLCε.Then MTT assay was performed for detecting cell proliferation,the changes of PCNA were analyzed by immunocytochemical method, Electron microscope was used to observe the morphological changes. Results: The specific PLC shRNA was confirmed to be efficient in silencing PLCε expression. PLCε gene down regulation by the shRNA recombinant plasmids inhibition cell proliferation rate about 78.01%, They were significantly different from that of control group (P〈0.01 ;After transfected the specific recombinant plasmids, PCNA expression was significantly decreased,They were significantly different from that of control group (P〈0.01 ;morphological changes produce apoptotic body. Conclusion: PLCε is likely to be potential molecular target for bladder carcinoma in gene therapy by RNAi.
出处
《重庆医科大学学报》
CAS
CSCD
北大核心
2009年第10期1313-1316,共4页
Journal of Chongqing Medical University
基金
重庆市教委科学技术研究项目互助(KJ080306)
关键词
膀胱癌
PLCε基因
RNA干扰
细胞增殖
增殖细胞核抗原
Bladder carcinoma
PLCεG gene
RNA interference
Cell proliferation
Proliferating cell nuclear antigen